Unipres (5949) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
12 Mar, 2026Executive summary
Net sales for Q3 FY2024 were ¥236,379 million, down 3.6% year-over-year, mainly due to reduced customer production despite favorable exchange rates.
Operating profit dropped to ¥2,966 million, a 39.6% decline year-over-year, reflecting lower sales and limited cost-saving impact.
Net income attributable to owners of parent was ¥108 million, down 95.6% year-over-year.
Financial highlights
Net sales fell by ¥8.7 billion year-over-year; operating profit decreased by ¥1.9 billion.
Ordinary profit for the quarter was ¥4,238 million, down 22.3% year-over-year.
Comprehensive income turned negative at ¥(2,779) million, compared to ¥23,267 million in the prior year.
Net income per share for the quarter was ¥2.43, down from ¥55.85 year-over-year.
Total assets at quarter-end were ¥316,791 million, down from ¥336,739 million at the previous year-end.
Outlook and guidance
FY2024 sales and operating profit forecasts were revised downward in November 2024.
Full-year FY2024 net sales forecast is ¥320,000 million, a 4.5% decrease year-over-year; operating income projected at ¥7,500 million, down 31.4% year-over-year.
Net income attributable to owners of parent is forecasted at ¥(20,000) million, with a net loss per share of ¥(448.61).
Dividend forecast for FY2024 is ¥60.00 per share, up from ¥35.00 in FY2023.
No significant rebound in client production is expected in the next fiscal year; business reorganization is planned.
Latest events from Unipres
- Operating profit rose despite lower sales, but net income was hit by one-time losses and FY2025 outlook is cautious.5949
Q4 202512 Mar 2026 - Operating profit and net income surged despite a 7.3% sales decline; outlook remains strong.5949
Q2 202612 Mar 2026 - Q1 FY2024 profits surged, with net income up 30% and strong full-year earnings guidance.5949
Q1 202512 Mar 2026 - First-half profits rose, but full-year outlook was cut amid lower demand and higher costs.5949
Q2 202512 Mar 2026 - Sales dropped 8.2% but operating profit and net income rose; full-year outlook remains cautious.5949
Q1 202612 Mar 2026 - Operating profit more than doubled despite a 4.8% drop in net sales.5949
Q3 202612 Mar 2026